ArticlePharmaceutics2022

Nano-Based Drug Delivery Systems of Potent MmpL3 Inhibitors for Tuberculosis Treatment.

Patrizia Nadia Hanieh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.